Enovis Corporation(ENOV) Stock Research - Grey Stern Research
Loading...

Enovis Corporation (ENOV) Stock Analysis

$46.40 (7.12%)

ENOV Financial Performance


Use the table below to view Enovis Corporation's financial profile. This data is gathers from the latest available financial statements. Annual data is taken from the trailing 12 months of statements. All numbers are reported in US Dollars and so any foreign currencies are converted to USD so comparison's can be done.

Based on Financial Statements from Q2 - 2024

Metric Value Ranking among Peers
Price $43.03 -
52 Week Low $38.27 -
52 Week High $65.03 -
Market Cap $2.4 Billion 8/15
Gross Margin 55% 2/15
Profit Margin -4% 14/15
EBITDA margin -4% 14/15
Q2 - 2024 Revenue $525.2 Million 6/15
Q2 - 2024 Earnings -$18.6 Million 15/15
Q2 - 2024 Free Cash Flow $0 Million 13/15
Trailing 4 Quarters Revenue $1.9 Billion 6/15
Trailing 4 Quarters Earnings -$90.6 Million 15/15
Quarterly Earnings Growth -86% 14/15
Annual Earnings Growth -15% 10/15
Quarterly Revenue Growth 23% 2/15
Annual Revenue Growth 16% 1/15
Cash On Hand $35.0 Million 13/15
Short Term Debt $15.0 Million 7/15
Long Term Debt $1.4 Billion 1/15

Enovis Corporation Financial Metrics


Financial metrics are a set of useful numbers that can give key performance indicators of a company. The various metrics can include information about profitability, growth, and debt load. When combined and use properly they can tell an analyst a compelling fact-based story of how the company is currently performing. To compare Enovis Corporation's metrics versus it's peers make sure to run our peer analysis tool.

Valuation Metrics

Metric Value Ranking among Peers
PE -1.00 14/15
PS 1.26 13/15
PB 0.73 14/15
PC 68.66 2/15
Liabilities to Equity 0.66 9/15
ROA -0.02 14/15
ROE -0.03 14/15
Current Ratio 2.53 6/15
Quick Ratio 0.02 14/15
Long Term Debt to Equity 0.42 4/15
Debt to Equity 0.42 4/15
Burn Rate 0.45 5/15
Cash to Cap 0.01 14/15
CCR 0.00 14/15
EV to EBITDA -204.03 14/15
EV to Revenue 1.97 12/15

Company Details

Enovis Corporation operates as a medical technology company worldwide. It develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports related injuries. It offers rigid and soft orthopedic bracings, hot and cold therapy products, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators used for pain management, and physical therapy products; and a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger. Enovis Corporation sells its products through independent distributors, such as healthcare professionals, consumer retail stores, and pharmacies; and directly under the DJO brand. The company was formerly known as Colfax Corporation. Enovis Corporation is headquartered in Wilmington, Delaware.

CEO:

Website: https://www.enovis.com

Address: 2711 Centerville Road Wilmington, DE

Exchange: New York Stock Exchange

Industry: Specialty Industrial Machinery

Enovis Corporation Peer Analysis


A useful and more reliable way of seeing the health of a company is to compare it to other companies operating in the same sector. Below is our list of companies which we rank are the closest peers to Enovis Corporation. If you feel that peers should be added or removed from this list please contact us. To run an in-depth peer analysis which compares many financial metrics click on the link below.

Stock Ticker Market Cap
IDEX Corporation IEX $17.0 Billion
Donaldson Company, Inc. DCI $9.0 Billion
EnPro Industries, Inc. NPO $3.1 Billion
ITT Inc. ITT $11.8 Billion
Franklin Electric Co., Inc. FELE $4.6 Billion
Watts Water Technologies, Inc. WTS $6.7 Billion
The Gorman-Rupp Company GRC $1.0 Billion
Graham Corporation GHM $315.7 Million
Kadant Inc. KAI $4.2 Billion
Hurco Companies, Inc. HURC $134.5 Million
Luxfer Holdings PLC LXFR $387.6 Million
Omega Flex, Inc. OFLX $527.8 Million
Helios Technologies, Inc. HLIO $1.6 Billion
Enerpac Tool Group Corp. EPAC $2.5 Billion
Run Peer Analysis
Income Statement
Balance Sheet
Cash Flow Statement
ENOV Income Statements
Quarter Year Revenue Earnings
Q2 2024 $ 525.2 Million -$18.6 Million
Q1 2024 $ 516.3 Million -$72.0 Million
Q4 2023 $ 455.0 Million $3.0 Million
Q3 2023 $ 417.5 Million -$2.9 Million
Q2 2023 $ 428.5 Million -$10.0 Million
Q1 2023 $ 406.2 Million -$22.8 Million
Q4 2022 $ 408.7 Million -$54.8 Million
Q3 2022 $ 383.8 Million -$65.9 Million

View All

ENOV Balance Sheets
Quarter Year Cash & Equivalents Total Assets Total Debt Total Equity
Q2 2024 $35.0 Million $5.4 Billion $1.4 Billion $3.3 Billion
Q1 2024 $66.3 Million $5.5 Billion $1.4 Billion $3.3 Billion
Q4 2023 $36.2 Million $4.5 Billion $536.4 Million $3.4 Billion
Q3 2023 $32.1 Million $4.4 Billion $444.2 Million $3.4 Billion
Q2 2023 $32.5 Million $4.4 Billion $447.6 Million $3.4 Billion
Q1 2023 $21.9 Million $4.3 Billion $357.4 Million $3.4 Billion
Q4 2022 $24.3 Million $4.3 Billion $310.5 Million $3.4 Billion
Q3 2022 $55.0 Million $4.4 Billion $525.1 Million $3.4 Billion

View All

ENOV Cash Flow Statements
Quarter Year freeCashFlow capitalExpenditure netChangeInCash
Q2 2024 $0 $0 $0
Q1 2024 -$73.1 Million -$36.9 Million $29.7 Million
Q4 2023 $40.5 Million -$27.9 Million $12.7 Million
Q3 2023 $4.0 Million -$27.0 Million -$362,000
Q2 2023 -$8.7 Million -$36.8 Million $10.6 Million
Q1 2023 -$23.0 Million -$30.4 Million -$2.4 Million
Q4 2022 -$72.7 Million -$36.8 Million -$30.7 Million
Q3 2022 -$1.5 Million -$20.9 Million -$40.6 Million

View All